Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis.

[1]  S. Ng,et al.  The changing epidemiology of liver diseases in the Asia–Pacific region , 2018, Nature Reviews Gastroenterology & Hepatology.

[2]  V. Wong,et al.  Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis , 2017, Hepatology.

[3]  Herbert Tilg,et al.  Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases , 2017, Gut.

[4]  V. Wong,et al.  Long‐term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study , 2016, Hepatology.

[5]  Shyi-Jang Shin,et al.  Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients , 2015, PloS one.

[6]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[7]  Aijaz Ahmed,et al.  Ethnic Disparities in the Association of Body Mass Index with the Risk of Hypertension and Diabetes , 2014, Journal of Community Health.

[8]  Anne Tybjærg-Hansen,et al.  Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease , 2014, Nature Genetics.

[9]  G. Targher,et al.  Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis , 2013, Nature Reviews Gastroenterology &Hepatology.

[10]  Chun-Jen Liu.  Prevalence and risk factors for non‐alcoholic fatty liver disease in Asian people who are not obese , 2012, Journal of gastroenterology and hepatology.

[11]  Shyi-Jang Shin,et al.  The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[12]  D. Lauderdale,et al.  Asian Americans Have Greater Prevalence of Metabolic Syndrome Despite Lower Body Mass Index , 2010, International Journal of Obesity.

[13]  G. Farrell,et al.  A fresh look at NASH pathogenesis. Part 1: The metabolic movers , 2010, Journal of gastroenterology and hepatology.

[14]  Henry Völzke,et al.  Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma‐glutamyl transpeptidase levels , 2009, Hepatology.

[15]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[16]  K. Kuo,et al.  Significant correlations between severe fatty liver and risk factors for metabolic syndrome , 2007, Journal of gastroenterology and hepatology.

[17]  Chien-Hua Chen,et al.  Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan , 2007, Journal of gastroenterology and hepatology.

[18]  Erick M Remer,et al.  The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[19]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[20]  L. Y. Wang,et al.  Abdominal sonographic screening in a single community. , 1990, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences.

[21]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[22]  L. Henry,et al.  NAFLD AND NASH: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention , 2018 .

[23]  Aijaz Ahmed,et al.  Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations. , 2014, World journal of hepatology.

[24]  S. Juo,et al.  Mitochondrial polymorphism 12361A>G is associated with nonalcoholic fatty liver disease. , 2012, Translational research : the journal of laboratory and clinical medicine.